par Vincent, Jean Louis 
Référence Current Drug Safety, 2, 3, page (227-231)
Publication Publié, 2007-09

Référence Current Drug Safety, 2, 3, page (227-231)
Publication Publié, 2007-09
Article révisé par les pairs
| Titre: |
|
| Auteur: | Vincent, Jean Louis |
| Informations sur la publication: | Current Drug Safety, 2, 3, page (227-231) |
| Statut de publication: | Publié, 2007-09 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Animals |
| Anti-Infective Agents -- adverse effects -- pharmacology -- therapeutic use | |
| Clinical Trials as Topic | |
| Drug Evaluation, Preclinical | |
| Humans | |
| Protein C -- adverse effects -- pharmacology -- therapeutic use | |
| Recombinant Proteins -- adverse effects -- pharmacology -- therapeutic use | |
| Sepsis -- drug therapy -- epidemiology -- physiopathology | |
| Severity of Illness Index | |
| Shock, Septic -- drug therapy | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1574-8863 |
| info:pmid/18690972 |



